Delivery Order SPE2DB20D3101-SPE2DB21FK5Q1
- Not listed
- This federal contract award is for the delivery of ZILRETTA 32 MG VIALS to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a wholly owned subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $2,297.76 and is a firm fixed-price delivery order with an ultimate completion date of October 18, 2021. The contract was awarded on September 24, 2021, and...
- This federal contract award is for the delivery of ZILRETTA 32 MG VIALS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $2,103.42, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of May 22, 2024. The contract is not designated...
- This federal contract award is for the delivery of ZILRETTA 32 MG VIALS to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $7,011.40, was awarded to Amerisourcebergen Drug Corp's Corporate Office division. It is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is October 16, 2024. No set-aside designation was used for this award. Amerisourcebergen is a major pharmaceutical distributor that holds...
- This federal contract award is for the delivery of ZILRETTA 32 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The $2,098.20 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 13, 2023 and was awarded on March 23, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of ZILRETTA 32 MG VIALS. The contract has a ceiling value of $1,402.28 and is structured as a Delivery Order with Firm Fixed Pricing. The contract does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,485.96, is for the delivery of ZILRETTA 32 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of March 25, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZILRETTA 32 MG VIALS, a pharmaceutical product, with a ceiling value of $1,485.96 and a period of performance through June 12, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $7,011.40, is for the provision of ZILRETTA 32 MG VIALS to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $1,051.71 for the supply of ZILRETTA 32 MG vials, a specialty pharmaceutical product. The contract has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp serves as the prime...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZILRETTA 32 MG VIALS, with a firm fixed-price ceiling value of $3,505.70 and a completion date of May 8, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., holds a larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB21FK5Q1Delivery Order
This federal contract award is for the delivery of ZILRETTA 32 MG VIALS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,659.20 and is a Firm Fixed Price Delivery Order. It was awarded on September 17, 2021, with an ultimate completion date of October 8, 2021. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 9/17/21 |